Annovis Bio (ANVS) traded up 1.01 % during a 24 hours period ending at 03:44 PM Central Europe on Monday 26th. One Annovis Bio stock can currently be bought for about USD 0.95 on popular exchanges. Current supply of Annovis Bio stocks is 42.6 mn. Annovis Bio has a current market capitalization of USD 42.6 mn and approximately USD 315.8 k worth of Annovis Bio was traded on exchanges in the last 24 hours. Since last month end, Annovis Bio has traded -24.81 % down. Simple moving average of last 200 days is at USD 1.98. The highest price of past 52 weeks was recorded at USD 5.5 on 11/28/2025. 52 weeks low was at USD 0.95 on 10/19/2026.
Here is how related stocks have performed in the past 24 hours:
Fluence (4SVE.F) traded flat 0 % and now trades at EUR 0.04. Current market capitalisation for Fluence is EUR 43.5 mn.
Intellicheck (IDN) traded up 1.67 % and now trades at USD 2.42. Intellicheck has a market capitalisation of USD 49.5 mn. Current price/earnings ratio for Intellicheck is 16.67.
Rein Therapeutics (RNTX) traded down -3.32 % and now trades at USD 0.58. Rein Therapeutics has a market capitalisation of USD 50.2 mn.
Xilio Therapeutics (XLO) traded down -5.73 % and now trades at USD 8.16. Current market capitalisation for Xilio Therapeutics is USD 49.8 mn.
Elicio Therapeutics (9HA.F) traded down -12.36 % and now trades at USD 1.74. Current market capitalisation for Elicio Therapeutics is USD 49.9 mn.
About Annovis Bio
Annovis Bio, Inc. is a biotechnology company based in Berwyn, Pennsylvania, United States. The company specializes in developing drugs for Alzheimer’s and Parkinson’s disease, including orphan indications like dementia and Alzheimer’s in Down syndrome. Annovis Bio serves customers in the state of Pennsylvania. You can find more information about their activities on their website, www.annovisbio.com , and they are listed on the New York Stock Exchange.
